SIC
MRNA icon

SJS Investment Consulting’s Moderna MRNA Stock Holding History

SJS Investment Consulting’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$762 Buy
+15
New +$700 ﹤0.01% 1584
2024
Q4 		– Sell
-20
Closed -$1.34K – 1668
2024
Q3 		$1.34K Buy
20
+1
+5% +$92 ﹤0.01% 965
2024
Q2 		$2.26K Buy
19
+2
+12% +$253 ﹤0.01% 656
2024
Q1 		$1.81K Buy
17
+1
+6% +$101 ﹤0.01% 797
2023
Q4 		$1.59K Sell
16
-7
-30% -$589 ﹤0.01% 760
2023
Q3 		$2.38K Buy
23
+10
+77% +$1.11K ﹤0.01% 568
2023
Q2 		$1.58K Buy
13
+7
+117% +$934 ﹤0.01% 696
2023
Q1 		$922 Sell
6
-13
-68% -$2.15K ﹤0.01% 927
2022
Q4 		$3.41K Buy
19
+12
+171% +$1.96K ﹤0.01% 435
2022
Q3 		$1K Buy
+7
New +$1.06K ﹤0.01% 824
2022
Q1 		$43K Hold
252
– – 0.01% 194
2021
Q4 		$64K Buy
+252
New +$73.7K 0.02% 155

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return